SPL7013 Gel (VivaGel®) retains potent HIV-1 and HSV-2 inhibitory activity following vaginal administration in humans (Q28740364)
Jump to navigation
Jump to search
scientific article (publication date: 2011)
Language | Label | Description | Also known as |
---|---|---|---|
English | SPL7013 Gel (VivaGel®) retains potent HIV-1 and HSV-2 inhibitory activity following vaginal administration in humans |
scientific article (publication date: 2011) |
Statements
SPL7013 Gel (VivaGel®) retains potent HIV-1 and HSV-2 inhibitory activity following vaginal administration in humans (English)
Clare F Price
David Tyssen
Secondo Sonza
Ashley Davie
Sonya Evans
Gareth R Lewis
Shirley Xia
Tim Spelman
Peter Hodsman
Thomas R Moench
Andrew Humberstone
15 September 2011
15 September 2011
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
2 references
2 references
2 references